Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)

PHASE3RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 9, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Sleep Wake DisordersSleep Disorders, Circadian RhythmChronobiology Disorders
Interventions
DRUG

Tasimelteon

oral capsule

DRUG

Placebo

oral capsule

Trial Locations (21)

1090

RECRUITING

Vanda Investigational Site, Vienna

4020

RECRUITING

Vanda Investigational Site, Linz

6020

ACTIVE_NOT_RECRUITING

Vanda Investigational Site, Innsbruck

10117

RECRUITING

Vanda Investigational Site, Berlin

11042

RECRUITING

Vanda Investigational Site, New Hyde Park

19053

RECRUITING

Vanda Investigational Site, Schwerin

20253

RECRUITING

Vanda Investigational Site, Hamburg

29201

RECRUITING

Vanda Investigational Site, Columbia

33176

RECRUITING

Vanda Investigational Site, Miami

35043

RECRUITING

Vanda Investigational Site, Marburg

44195

RECRUITING

Vanda Investigational Site, Cleveland

45212

RECRUITING

Vanda Investigational Site, Cincinnati

55905

RECRUITING

Vanda Investigational Site, Rochester

63123

RECRUITING

Vanda Investigational Site, St Louis

75071

RECRUITING

Vanda Investigational Site, McKinney

78229

RECRUITING

Vanda Investigational Site, San Antonio

80045

RECRUITING

Vanda Investigational Site, Aurora

81377

RECRUITING

Vanda Investigational Site, Munich

90025

RECRUITING

Vanda Investigational Site, Los Angeles

94063

RECRUITING

Vanda Investigational Site, Redwood City

02115

RECRUITING

Vanda Investigational Site, Boston

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY